← All organizations
Highest phase reached
Phase 4
Acquired by Halozyme Therapeutics on Apr 14, 2022
Timeline
1970s
- Jul 1, 1979
Antares Pharma Inc.— Founded
2010s
- Oct 11, 2013
naltrexone— NDA Secondary Org
- Dec 10, 2015
sumatriptan— Marketing Organization
2020s
- Apr 14, 2022
Halozyme Therapeutics— Acquired By
Drugs by trial phase (5 distinct, 10 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Marketed drugs (3)
Recent trials (10)
- NCT04601233CollaboratorPhase 4Dec 31, 2021
- NCT04879589CollaboratorPhase 1Jun 10, 2021
- NCT02777242Lead sponsorPhase 2Jun 1, 2016
- NCT02504541Lead sponsorPhase 3Jul 1, 2015
- NCT02233751Lead sponsorPhase 1Sep 1, 2014
- NCT02159469Lead sponsorPhase 3Jul 1, 2014
- NCT01887418Lead sponsorPhase 1/Phase 2Sep 1, 2013
- NCT01618968Lead sponsorPhase 2May 1, 2012
- NCT01737944Lead sponsorPhase 1/Phase 2Jan 1, 2011
- NCT00909181Lead sponsorPhase 3Mar 1, 2009
Details
- Founded
- Minneapolis, MN, US Jul 1, 1979
- Last known activity
- Mar 28, 2022